Multidrug-resistant tuberculosis [1]

New England Journal of Medicine

Volumn 334, Issue 4, 1996, Pages 267-269

  Iseman, M D ^a   Goble, M ^a   Carlos, L ^a   Da Silva, C ^a   Muller, L ^a   Di Perri, G ^a   Vento, S ^a   Concia, E ^a   Cazzadori, A ^a   Telzar, E E ^a   Sepkowitz, K ^a   Tureti, G ^a  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; AMIKACIN; QUINOLONE DERIVATIVE; TUBERCULOSTATIC AGENT;

CLINICAL ARTICLE; DRUG EFFICACY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MULTIDRUG RESISTANCE; PATHOGENICITY; PRIORITY JOURNAL; RELAPSE; STRAIN DIFFERENCE; TREATMENT FAILURE; TUBERCULOSIS; BRAZIL; CLINICAL TRIAL; DRUG COMBINATION; NOTE; SERODIAGNOSIS; TREATMENT OUTCOME; LUNG RESECTION; UNITED STATES;

AMIKACIN; ANTITUBERCULAR AGENTS; BRAZIL; DRUG THERAPY, COMBINATION; HIV SERONEGATIVITY; HUMANS; QUINOLONES; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; COLORADO; NEW YORK CITY; PNEUMONECTOMY;

EID: 0039017981     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199601253340413     Document Type: Letter

References (0)